DeFi Technologies Inc., a financial technology company at the forefront of decentralized finance (DeFi) and digital asset innovation, has increased its stake in Neuronomics AG, a Swiss asset management firm specializing in artificial intelligence and computational neuroscience, to 52.5%. This strategic acquisition strengthens DeFi Technologies' presence in AI-driven asset management and trading while complementing its DeFi Alpha arbitrage trading desk.

Neuronomics, a FINMA-licensed Swiss asset management firm, leverages AI and computational neuroscience to develop advanced model-driven quantitative trading strategies. These proprietary AI algorithms have consistently outperformed market benchmarks, delivering superior risk-adjusted returns. By integrating Neuronomics' cutting-edge AI technology, DeFi Technologies aims to enhance its asset management capabilities and diversify revenue streams in both traditional and decentralized financial markets.

With a focus on AI-powered financial strategies, Neuronomics combines Large Language Models (LLMs) and neurofinance-based analytics to optimize trading decisions. Its proprietary models analyze real-time market news, sentiment, and trading behaviors, providing early insights into asset price movements. This technology has demonstrated 80% annualized returns in forward testing, significantly reducing volatility and drawdowns compared to passive market exposure. The acquisition strengthens DeFi Technologies' ability to navigate dynamic market conditions while capitalizing on AI-driven investment strategies.

"This acquisition marks a pivotal moment for DeFi Technologies as we integrate Neuronomics' AI and computational neuroscience expertise into our ecosystem," said Olivier Roussy Newton, CEO of DeFi Technologies. "With their quantitative trading strategies and AI-powered research, we are well-positioned to enhance our asset management offerings and further develop innovative financial solutions that bridge traditional and decentralized finance."

The acquisition includes the issuance of 186,304 common shares of DeFi Technologies, with a portion subject to a lock-up schedule, along with additional cash considerations. No finder fees were paid in connection with the transaction. The completion of the acquisition remains subject to Cboe Canada Exchange approval. Moving forward, DeFi Technologies and Neuronomics will collaborate on expanding AI-driven trading solutions, reinforcing their shared vision of advancing next-generation asset management technologies.